Skip to main content

L Pillai

First name:
L
Last name:
Pillai
Kumar, R. ., Prem, S. ., Mahapatra, M. ., Seth, T. ., Chowdhary, D. ., Mishra, P. ., … Choudhry, V. . (2006). Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplantation, 37(8), 745-9. https://doi.org/10.1038/sj.bmt.1705321
Pillai, L. ., Sha, J. ., Erova, T. ., Fadl, A. ., Khajanchi, B. ., & Chopra, A. . (2006). Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila. Infection and Immunity, 74(7), 3742-55. https://doi.org/10.1128/IAI.00402-06
Pillai, L. ., Chouvarine, P. ., Tudor, C. ., Schmidt, C. ., Vijay-Shanker, K. ., & McCarthy, F. . Developing a biocuration workflow for AgBase, a non-model organism database. Database : The Journal of Biological Databases and Curation, 2012, bas038. https://doi.org/10.1093/database/bas038 (Original work published 2012)
Srinivas, U. ., Pillai, L. ., Kar, R. ., Mahapatra, M. ., Gujra, S. ., & Pati, H. . (2007). A case of rhabdomyosarcoma masquerading as acute leukemia at presentation: a case report. Indian Journal of Pathology & Microbiology, 50(4), 917-9.
Yanow, J. ., Pappagallo, M. ., & Pillai, L. . (2008). Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. TheScientificWorldJournal, 8, 229-36. https://doi.org/10.1100/tsw.2008.33 (Original work published 2008)
Kumar, N. ., Hinduja, I. ., Nagvenkar, P. ., Pillai, L. ., Zaveri, K. ., Mukadam, L. ., … Bhartiya, D. . (2009). Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house-derived human feeders. Stem Cells and Development, 18(3), 435-45. https://doi.org/10.1089/scd.2008.0234
Zimmerman, P. ., d’Audiffret, A. ., & Pillai, L. . (1969). Endovascular repair of blunt extremity arterial injury: case report. Vascular and Endovascular Surgery, 43(2), 211-4. https://doi.org/10.1177/1538574408326181 (Original work published 1969)
Pillai, L. ., Burnett, B. ., Levy, R. ., & Cooperative, G. G. S. (2010). GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin. Current Medical Research and Opinion, 26(5), 1055-63. https://doi.org/10.1185/03007991003694522
Pillai, L. ., Levy, R. ., Yimam, M. ., Zhao, Y. ., Jia, Q. ., & Burnett, B. . (2010). Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies. Advances in Therapy, 27(6), 400-11. https://doi.org/10.1007/s12325-010-0040-7
Levy, R. ., Khokhlov, A. ., Kopenkin, S. ., Bart, B. ., Ermolova, T. ., Kantemirova, R. ., … Burnett, B. . (2010). Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in Therapy, 27(10), 731-42. https://doi.org/10.1007/s12325-010-0064-z